Glyco Expression Technologies, spun out of University of Georgia's Complex Carbohydrate Research Center, was founded to develop and commercialize mammalian expression technology. The company's expression platform aims to provide high-throughput custom production of complex glycosylated biomolecules for research and industry. The company develops a range of products that all employ a proprietary Glo-Enzyme fusion protein strategy that provides efficient production and secretion in mammalian cells. The products are flexible and suited for diverse biochemical, analytical, synthetic, cell biology and biotherapeutic applications.
